Poster: ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival

MLA

Jordi Ribera, et al. “Poster: ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival.” Clinical Lymphoma Myeloma and Leukemia, vol. 22, Oct. 2022, p. S121. EBSCOhost, https://doi.org/10.1016/s2152-2650(22)00720-0.

APA

Jordi Ribera, Isabel Granada, Teresa González, Mireia Morgades, Ricardo Sánchez, Esperanza Such, Susana Barrena, Juana Ciudad, Beatriz Soriano, Rocío Benito, Gayane Avetisyan, Eva Lumbreras, Cristina Miguel, Sandra Santos, Lurdes Zamora, Mar Mallo, Eulàlia Genescà, Celia González, Thaysa Lopes, … Josep Maria Ribera. (2022). Poster: ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival. Clinical Lymphoma Myeloma and Leukemia, 22, S121. https://doi.org/10.1016/s2152-2650(22)00720-0

Chicago

Jordi Ribera, Isabel Granada, Teresa González, Mireia Morgades, Ricardo Sánchez, Esperanza Such, Susana Barrena, et al. 2022. “Poster: ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival.” Clinical Lymphoma Myeloma and Leukemia 22 (October): S121. doi:10.1016/s2152-2650(22)00720-0.